Brain natriuretic peptide

There are 85 papers on brain natriuretic peptide in aging research: 11 trials and 49 observational studies in people, 13 in animals, 1 in cells, 7 reviews.

Biomarker

85 papers study it160 more mention it24 findings

10 new papers in 30 daysSee all 245 papers on brain natriuretic peptide

“Significant depressive symptoms were associated with Log BNP levels (β=0.56, P = 0.02).”
Association of depressive symptoms with cardiovascular events and plasma BNP: A prospective cohort study of the elderly Chinese populationArchives of gerontology and geriatrics2024doi:10.1016/j.archger.2024.105413
  • Human trial11
  • Humans49
  • Animals13
  • Cells1
  • In silico1

Interventions

3

Cardiac rehabilitation

downin humans1

1 study
  1. Cardiac rehabilitation is linked with lower brain natriuretic peptide in HFrEF patients with CKD (688 vs 488 pg/mL, P < .001).

    Humansin HFrEF patients with CKD4-wkn = 567

More on Cardiac rehabilitation

Baduanjin

no changein humans1

1 study
  1. Baduanjin showed no clear effect on brain natriuretic peptide in humans (chronic heart failure).

    Human trialchronic heart failure12 weeksn = 103

More on Baduanjin

SGLT2 inhibitors

downin humans1

1 study
  1. SGLT2 inhibitors are linked with lower brain natriuretic peptide in patients with brain natriuretic peptide above the upper limit before treatment.

    Humansin patients with brain natriuretic peptide above the upper limit before treatment6 monthsn = 78

More on SGLT2 inhibitors

Effects

1

Mortality

no changein humans1

1 study
  1. Brain natriuretic peptide was not clearly linked with mortality in humans (hip fracture surgery, primary multivariate logistic regression analysis) (p = 0.081).

    Humanship fracture surgery, primary multivariate logistic regression analysis90-dayn = 133

Associations

15

Mortality

upin humans6HR 1.26–1.44

6 studies
  1. Brain natriuretic peptide is associated with mortality in humans (hospitalized Japanese older patients with a risk of infection) (HR 1.26 (0.89-1.76)).

    Humanshospitalized Japanese older patients with a risk of infection30 days

  2. Brain natriuretic peptide predicts mortality in patients with heart failure and sarcopenia.

    Humansin patients with heart failure and sarcopenia

  3. Brain natriuretic peptide is linked with a higher risk of mortality in humans (hypertension without symptoms of heart failure) (HR 1.44, 95% CI 1.07 to 1.94).

    Humanshypertension without symptoms of heart failureup to 9 yearsn = 530

  4. Brain natriuretic peptide is associated with mortality in humans (hip fracture surgery) (p = 0.038).

    Humanship fracture surgery90-dayn = 133

  5. Brain natriuretic peptide predicts mortality in humans (surgically treated hip fractures).

    Humanssurgically treated hip fractures2 yearsn = 455

  6. Brain natriuretic peptide predicts mortality in humans (proximal femur fracture).

    Humansproximal femur fracturen = 112

Incident atrial fibrillation

upin humans1

1 study
  1. Brain natriuretic peptide predicts incident atrial fibrillation in humans (Prospective studies measuring BNP prior to onset).

    ReviewProspective studies measuring BNP prior to onset

More on Incident atrial fibrillation

Atrial fibrillation

upin humans1

1 study
  1. Brain natriuretic peptide is associated with atrial fibrillation in humans (Prevalent atrial fibrillation) (Pooled standardized mean difference 1.08; 95% CI 0.67–1.49; P < 0.0001).

    ReviewPrevalent atrial fibrillation

More on Atrial fibrillation

Single-lead electrocardiography

upin silico1

1 study
  1. Single-lead electrocardiography predicts brain natriuretic peptide in silico (testing dataset) (macro-average AUC 0.87 ± 0.03).

    In silicotesting datasetn = 105,712

More on Single-lead electrocardiography

Third lumbar level psoas muscle index

downin humans1

1 study
  1. Third lumbar level psoas muscle index is associated with brain natriuretic peptide in humans (patients waitlisted for kidney transplant) (P < .01).

    Humanspatients waitlisted for kidney transplantn = 172

More on Third lumbar level psoas muscle index

Acylcarnitines

upin humans1

1 study
  1. Brain natriuretic peptide is associated with acylcarnitines in humans (patients who underwent surgery for cardiovascular diseases) (β = 0.273, p = 0.011).

    Humanspatients who underwent surgery for cardiovascular diseasesserumn = 117

More on Acylcarnitines

Depressive symptoms

upin humans1

1 study
  1. Depressive symptoms are associated with brain natriuretic peptide in humans (significant depressive symptoms) (β=0.56, P = 0.02).

    Humanssignificant depressive symptomsn = 1,432

More on Depressive symptoms

Heart failure

upin humans1HR 3.88

1 study
  1. Brain natriuretic peptide is linked with a higher risk of heart failure in humans (hypertension without symptoms of heart failure) (HR 3.88, 95% CI 2.13 to 7.10).

    Humanshypertension without symptoms of heart failureup to 9 yearsn = 530

More on Heart failure

Cardiovascular disease

upin humans1HR 1.45

1 study
  1. Brain natriuretic peptide is linked with a higher risk of cardiovascular disease in humans (hypertension without symptoms of heart failure) (HR 1.45, 95% CI 1.15 to 1.82).

    Humanshypertension without symptoms of heart failureup to 9 yearsn = 530

More on Cardiovascular disease

Postoperative complications

upin humans1

1 study
  1. Brain natriuretic peptide predicts postoperative complications in humans (surgically treated hip fractures).

    Humanssurgically treated hip fractures2 yearsn = 455

All 15

Funding

1 grant since 2024

National Heart, Lung, and Blood Institute$1M

Latest

Dec 2025: 3Jan 2026: 6Feb 2026: 5Mar 2026: 2Apr 2026: 3May 2026: 0Jun 2026: 4Jul 2026: 2Aug 2026: 6Sep 2026: 3Oct 2026: 7Nov 2026: 546 papers in 12 months

See all 245 papers on brain natriuretic peptide